Betterpath is a Title III - Regulation Crowdfunding Campaign and is actively accepting investments.
$470.00 minimum investment


A Better Health Savings Account (HSA)

Small OPO
Brooklyn, NY
Consumer Products
Accepting International Investment

A $100 Billion Market for Personal Data Only Exists Because You "Agree" to Give Your Data Away For Free

Invest in Betterpath

Right now, your data is collected, bought and sold by Data Brokers who rely on you as their only product.  As the Data Owner, we believe you're the only one who can get all your data in one place, improving its value dramatically.


Data Owners unfortunately cannot prevent their data from being bought and sold.


Data Owners can increase the value of their data by exercising their right to get it all in one place. 


Betterpath makes it easy for Data Owners to get all their data in one place, and get paid for it.


Betterpath is launching a Health Savings Account (BetterHSA) that helps Data Owners control their health data as a financial asset. 

To bypass the resistance most consumers feel toward "sharing data", we will make adoption a no-brainer. Our strategy is to pay high-deductible health plan holders (40% of U.S. Adults) up to $500 to adopt our Health Savings Account. 

Protecting Data Owner's privacy and security is Betterpath's #1 Priority. No data will ever be exposed to Data Buyers without the Owner's explicit consent.

Users control every aspect of who can access their data, and how their data is used

Identifiers (e.g. SSN, Name, Address) are removed and stored with an FDIC-insured custodian

Users determine which data is transacted with Buyers and can adjust their Terms at any time

Platform compliant with strictest regulations, allows Users to download/remove data at any time

Health Data Holds the Biggest Opportunity

In the information economy, medical records + health data hold immense value: A single Health Data Buyer (like a Pharma / Biotech company, Marketing Agency, or Insurer) can spend up to $12M EACH YEAR to access "anonymized" health data.

We believe Data Buyers want a more robust product, and Data Owners hold the key

Betterpath's Cooperative Data Brokerage Model will connect the Buyer's demand with the Owner's supply through the BetterHSA.

The BetterHSA 

Helping Consumers turn their fragmented health data into a valuable asset.

“Our view is that everyone will have HSAs. They’ll be completely portable. They’ll have every investment option available to them that is available today in the investment world. They’ll become ubiquitous across all aspects of our lives.

Walt Bettinger, CEO of Charles Schwab, November, 2017

If you have a High-deductible Health Plan and no other insurance plan, you likely qualify for an HSA

BetterHSA Product Development

  • Stage: Market Acceptance / Beta (launch anticipated August 2018)
  • Requirements: Collect "minimum viable data" for proof-of-concept
  • Current working features:
    • HSA Transaction Summary
    • Integrated transaction tracker
    • In-app chat support + opportunity inbox

Why Betterpath Will Use Blockchain

  1. to setup a Network of dynamically permissioned Owners and Buyers 
  2. to maintain a secure, detailed ledger of financial transactions
  3. to ensure unlimited capacity and scalability

Betterpath Platform Development

  • Stage: Development / Beta
  • Requirements: secure permissioning mechanisms to track the collection, access, and commercial use of personal data
  • Current Infrastructure: HIPAA / GDPR / HITRUST CSF-compliant cloud.
  • Planned Infrastructure: Ethereum-based or Cardano-based blockchain for user-directed permissioning and transparent financial accounting (anticipated migration Q2'19)

Why Betterpath Avoids Using a "Cryptocurrency"

  1. We believe the typical consumer doesn't care about crypto, and will prefer a $USD-based incentive structure
  2. We believe crypto (or "Utility Tokens") only make sense once a fully functioning Network of buyers and sellers is established
  3. We believe digital currencies will evolve rapidly over the next 5 years, and we can't predict the future

The Offering

Investment: Series A Preferred Stock & CDX Tokens

$4.70/share of Series A Preferred Stock

By investing in Betterpath, you are confident the Company's future equity value will exceed $25,568,009.40


CDX Tokens

The Offering includes 100% match of 20 CDX Tokens for every $1 invested.  ($0.050 / Token)

Our anticipated Reg A+ round will authorize 1,500,000,000 CDX and offer 478,600,053 CDX for public sale at $0.050 / Token.

Additional Perks*

  • Up to $750: Early access to BetterHSA Private Beta
  • Up to $1000: Early access to BetterHSA Private Beta + 1 referral code
  • Up to $2500: Early access to BetterHSA Private Beta + 2 referral codes
  • Over $5000: Early access to BetterHSA Private Beta + 3 referral codes 

*All perks and tokens will be delivered after the campaign is completed, and upon availability of the Tokens.  See Offering Summary below for additional terms.

Once Betterpath becomes profitable, the Company will deposit 50% of its profits into the CDX Trust that will provide a redemption value for the CDX Tokens.

Betterpath anticipates that successful rollout of the BetterHSA will create an increasingly valuable network of health data owners and buyers. This network is called the Consumer-directed Exchange (CDX).

CDX Tokens

CDX is a "Tokenized Security" that investors in this offering will receive as a perk for participating. CDX will be allocated to equity investors as a reward for our early supporters. This provides investors with a secured interest in the profits generated by the Consumer-directed Exchange, and a possible path to early liquidity following our anticipated Reg A+ Tokenized Security Offering in the latter part of this year.

  • The right to tokens is contingent upon the successful development of such Tokens and to the extent applicable, the blockchain upon which they function.  There is no guarantee that successful development will ever occur.
  • We intend to implement the tokens on Ethereum's ERC20 blockchain with a planned migration to Cardano sometime toward the end of 2019.
  • The value of the tokens will be backed in $USD through a Trust Account (CDX Trust) that will administer the receipt and deposit of 50% of Betterpath’s profit on data sales from the Consumer-directed Exchange. 
  • These funds, which will be held in a separate legal entity, will be available for all CDX Token holders to use as a redemption vehicle and allow for each CDX token to have a $USD-backed NAV (Net Asset Value).

For details on the bonus, please see the Offering Summary below.

We anticipate Betterpath's Cooperative Health Data Brokerage model will become self-sustaining over time

Costs per User Acquisition Decrease as User Growth Scales

* YEAR 1: We will pay users to Signup ($350), and provide initial Data Incentive Payments (up to $150) to stimulate early data volume. Operational costs are estimated at $120/user. 

** YEAR 5: User demand for BetterHSA removes need to pay for Signup, and Data Incentive Payments will come directly from Data Buyers. Operational costs fall to $80/user as scalability is reached.

Value per User Increases as Critical Mass is Reached in Certain Disease States

* YEAR 1: A typical user's dataset will be worth an estimated $2000/year based on average data contributions and engagement (see "Commercial Revenue Assumptions" below)

** YEAR 5: Assuming Betterpath can capture 5% of the overall HSA market within the first 5 years, the same user's dataset could be worth up to $15,000 based on a 50% increase in value upon reaching critical mass in certain cohorts (e.g. in a disease or medication subgroup that's in high demand). 

Paying users to adopt will help us reach critical mass early

Beta users will be compensated in up to $500 cash just for signing up and contributing data.

*Estimates based on fully subscribed Reg CF Offering

Why Health Savings Accounts?

  • We believe the HSA market is experiencing rapid growth among consumers who are concerned about the rising cost of healthcare.


  • *Betterpath has signed an MOU with Prime Trust, LLC (an FDIC-insured national trust company) to be the initial custodian for BetterHSA funds and accounts. 

40% of US adults (~100M people) may qualify for an HSA, yet only 21M people use them


Betterpath will close the HSA adoption gap: 

  1. By targeting financially under-saved High-deductible Health Plan holders like Millennials 
  2. By targeting medically over-burdened populations like chronic disease patients, their families and caregivers

Due to their unique tax advantages, HSAs are now being looked at as “the retirement account of the future”

HSAs provide better tax advantages than traditional 401(k) and Roth IRA retirement accounts

BetterHSA Features

The features of the BetterHSA provide a user experience similar to that of a mobile banking app. 

As users become familiar with managing their health-related finances through this tool, 

Betterpath presents opportunities for them to monetize their data. 

By positioning BetterHSA as a financial tool, Betterpath reduces consumer resistance to sharing health data

Health Savings Account

With our BetterHSA, you can seamlessly access your transaction history and track your purchases.  The financial view shows deposits, withdrawals, and earnings in one simple interface. An image capture tool helps users track any HSA expenditures (required for tax purposes), as well as prescriptions. Additionally, by partnering with FDIC-insured financial custodians, BetterHSA will provide users with investment options similar to traditional HSAs.

Anticipated release: September 2018

Computer-generated picture - Final product may vary


Track your prescriptions and gain access to discounts and support programs through our Rx Marketplace. Upcoming API integrations with other online platforms for health services, including pharmacy and telemedicine, allow users to coordinate and track healthcare activities from across the continuum of care. 

Anticipated release: October 2018

Computer-generated picture - Final product may vary


“Learn more about your options while improving the value of your data.” Concierge support tool provides users with access to a live person for help with self-directed investments and HSA transfers. Upcoming chat-bot integrations allows users to seek answers to health-related questions privately and creates a compelling user experience. This makes it easier to fill data gaps and improve the value of user’s data asset.

Anticipated release: October 2018

Computer-generated picture - Final product may vary

Data Score

Provides a data completeness “score” (like a credit score) that ranks the fair market value of a user’s data based on their Opt-Ins. This unlocks an enormous opportunity for both Betterpath and its users to realize accretive financial gain, and sets the stage for our self-sovereign data marketplace: the Consumer-directed Exchange.

Anticipated release: December 2018

Computer-generated picture - Final product may vary

Betterpath's Business is "Data Arbitrage"


Since data lives everywhere, Betterpath will maintain an Open API that allows data from apps, wearables, and web portals to be ingested and added to the data collected through BetterHSA.


Where possible, Betterpath will rely on data storage capabilities currently available on most mobile device platforms, and create a "Personal Grid" approach that drastically reduces risk of large-scale breach.


Interoperability is solved through a network of APIs that allow Betterpath to transform health data into a concept-based language, available open-source through the National Libraries of Medicine (UMLS CUIs).

Users Control Every Aspect of How Their Data is Monetized

By opting-in to opportunities like receiving targeted advertisements, fulfilling sponsored surveys, and learning about research studies, users will have full control over how their data is monetized. Betterpath users will receive monetization opportunities based on the marketplace demand for their data (typically disease-state based), meaning that users with chronic diseases where competing therapies are available will benefit from the more lucrative monetization opportunities.

Our "Cooperative Data Brokerage" taps into Big Markets 

Unlike traditional data brokers, who transact billions each year selling access to data without sharing profits, Betterpath will pay cash ($USD) to its users. We plan to utilize blockchain technology and advanced cryptographic security technologies to help users set and track the data use, disclosure, and access of health information, ensuring consumers are always in control and properly compensated when they authorize their health data assets to be monetized. 

How Each Revenue Source Works

Sponsored Messages + Survey Delivery

Currently, Pharma and Biotech companies purchase advertising space across a variety of web and mobile publishers to deliver messages and collect insights about their target audience.

Example of content-targeted ads on

From new patient acquisition to fostering medication compliance, drug makers spend billions to promote and educate their intended audiences about their products, but current targeting is mostly content-based and does not ensure message delivery to the intended target.  

BetterHSA will go beyond current healthcare media options and provide a hyper-targeted distribution mechanism for these messages and programs compared to the content-based targeting that currently drives billions of dollars in healthcare advertising spending

  • Surveys and messages will be delivered directly to the in-app Inbox and are designed to be as relevant as possible to ensure users are not overburdened. 

  • Financial incentives will manifest in the BetterHSA directly, or can be realized within the Marketplace where the user will simply benefit from the discounted price of each product offered in the BetterHSA marketplace. 

  • Drug makers will pay Betterpath to identify qualifying targets and communicate targeted program messages. Tracking post communication impact will be done through the BetterHSA, providing advertisers a trackable ROI and re-targeting opportunity.

Comprehensive Dataset Access


Current Dataset Access Example: (1) When you fill a prescription, the pharmacy collects two data points. (2) The data broker purchases and aggregates these data points from multiple pharmacies, getting Rx type and location on 1000 users at an estimated price of $2.00/user*. (3) Drug maker purchases access to this 2000 point dataset at an estimated price of $7.50/data point*. Even though you are the rightful owner of that data, you don’t see a penny.

*This hypothetical example illustrates the data transaction process. Price estimates provided are based off Betterpath's real-world experience in working with drug makers and data brokers.


Betterpath Dataset Access Example: (1) BetterHSA captures 4 additional data points during the user registration process. (2) Betterpath plays the role of data broker, aggregating 6 data points from 1000 BetterHSA users. (3) Drug makers purchase access to this 6000 point data set at the same price per data point. Betterpath keeps 10% for operational overhead, then splits the remaining profits among the BetterHSA users who contributed to the data set sale.

By capturing more data on each user, Betterpath can offer drug makers a more comprehensive view of the same population, increasing the market value of a dataset sale dramatically. This allows Betterpath to share profits with our users while still capturing higher revenues than typical data brokers. Since this data can be sold repeatedly to multiple buyers, Betterpath and BetterHSA users jointly create a "Data-as-a-Service" or DaaS product offering to an industry that is already paying billions each year for data that is fragmented and limited.

Research Qualification

Currently, we believe the ability for Pharma and Biotech to identify eligible candidates for clinical trials is greatly limited by several factors, including insufficient access to the data required to determine whether a person meets inclusion and exclusion criteria for the trial, and continued reliance on resource-intensive methods to inform potential candidates of trial opportunities. 

These factors are the main reason why up to 29% of clinical trial budgets are dedicated to recruiting participants, with the average cost to enroll a single participant exceeding $30,000.

BetterHSA serves as a hub for research organizations to address both of these barriers by providing access to the data required to determine inclusion and exclusion, and maintaining direct contact with users who have opted to be contacted for research opportunities. 

By using patent-pending data extraction and transformation technologies designed explicitly to identify highly detailed criteria from within a user’s medical records, Betterpath can drastically reduce the average cost of enrollment and provide research organizations with an ongoing supply of trial candidates. 

Cashflow Projections and Commercial Revenue Assumptions

March 2020 Milestones


  • > 30,000 users
  • > 20 commercial contracts
  • > $12,000,000 recurring revenue (ARR)
  • > $5,000,000 in profit-sharing to users


  • > 2.5M Data Points in Commercial Dataset
  • > 100 Data Points per User
  • > 3 Disease-specific Data Cohorts


  • Blockchain permissioning system
  • Cryptographically secure ecosystem
  • Mobile data extraction, transformation, and loading (ETL)

BetterHSA Channel Partners will help us scale user adoption

Partnership Strategy

To market the unique value proposition of the BetterHSA, Betterpath will engage Channel Partners who are interested in expanding their current customer base, strengthening relationships with existing customers, and generating passive revenue. 

Channel Partners will include financial institutions, health and wellness organizations, non-profits, and employer-facing services companies (such as third-party benefits administrators). 

Additionally, Betterpath is already discussing Marketplace Partnerships with several consumer-facing organizations that sell health and wellness products, setting the foundation for a robust in-app Marketplace that provides users with discounts on relevant HSA-covered items.

Partnership Timeline


  • Prime Trust (an FDIC-insured trust company) signed MOU to become BetterHSA’s initial financial custodian
  • Initiated discussions with mid-size Community Bank to offer BetterHSA to their 100,000+ customers


  • Partner with Patient Advocacy groups within disease verticals where data is in greatest demand (oncology & autoimmune diseases) (Anticipated)
  • Scale user acquisition through partnerships with Third-party Benefits Administrators (Anticipated)


  • Expand partnerships to include large Commercial Bank in nationally co-branded or joint venture offering (Anticipated)

Key Achievements to Date

IHSM Patent (2012)

“Integrated Healthcare Systems and Methods” (US Patent 9,202,066) is our evidence-based medicine protocol that determines optimal treatment pathways in all diseases through long-term comparative cost analysis.

Big Data Tests (2015)

Tested assumptions around structured EHR and Insurance data with 3.5M+ patient records. Found that pervasive inaccuracy and lack of detail rendered these datasets unusable for clinical outcomes research.

Recap PHR (2016)

Our first product, the Betterpath Recap, is a comprehensive personal health record designed to give chronic disease patients control of their entire medical history. The Recap was in-market from 2013-2016 (350 users). Check out the demo here.

UMLS Data ETL (2017)

Our unique utilization of the NLM’s Unified Medical Language System (UMLS®) creates an Extract-Transform-Load (ETL) approach that refines all formats of health data into a cohesive, interoperable language. Check out the demo here.

What's the Endgame?

By paying consumers each time their health data is accessed and used, Betterpath seeks to motivate consumers to take control of their health data as a valuable asset, building a Network that uniquely aligns all health system stakeholders through easier access to more comprehensive information. 

In the Network, earning potential for the consumer will grow in accordance with both the volume of their data contributions, and with the level of data access authorized for monetization opportunities. Because all data is controlled by each individual contributor, Users who authorize greater access to more data are rewarded more generously. 

The Network will build the foundation for a new cooperative economy based on the collective social utility of comprehensive information. In a cooperative, nobody wins unless everybody wins - Betterpath is committed to this vision. 

Our Network is a Consumer-directed Exchange (CDX)

The creation of a CDX based upon a fair exchange of value between consumers and industry is the most critical step toward developing an agnostic database that benefits all healthcare stakeholders, starting with the user.

The CDX functions as a decentralized data bank, while a platform of patented data capture and refinement technologies serve as a clearinghouse, standardizing low-value, unstructured data into actionable, high-value datasets. 

As the digital asset marketplace continues to evolve, Betterpath's CDX could create the opportunity to pilot the first cryptocurrency that's backed by the monetary value of personal data. While we don't know what the future holds, we're beyond excited by the prospect that one day, Betterpath will enable people to pay for everyday items with their data. 

Who We Are is How We're Different

  • Betterpath’s goal of complete, consumer-owned health data has rallied some of the industry’s leading experts from the highest levels of academia, government and the private sector. 
  • Many have spent the majority of their careers in pursuit of this elusive goal, and collectively bring more than a century of relevant experience in consumer technology, executive leadership, healthcare informatics and data interoperability. 
  • Now, with the combined wisdom and insights of a highly accomplished interdisciplinary team, Betterpath is uniquely positioned to execute on this vision and finally bring a consumer-centric, data-driven health system to bear. 

Wisdom is our "key differentiator"

In the Press

“Health - Wealth: 9 Steps to Financial Recovery”
January 18, 2018

"As it relates to employers directly, there are organizations offering consumer-centric machine learning programs. One industry leader, Betterpath, describes its platform as ‘harmonizing disparate healthcare activities simply by getting all of one’s patient data in one place.'"

Our Bodies, Our Data: How Companies Make Billions Selling Our Medical Records
February 6, 2018

In this seminal book on data privacy and security, Adam Tanner highlights Betterpath's unique commitment to transparency, identifying Betterpath as one of the only 'data brokers' that clearly outlines how it sells data directly in its "Terms of Service".

Offering Summary

Maximum 227,659 shares of 8% Series A Preferred Stock* ($1,069,997.30)

*Maximum subject to adjustment for bonus shares. See 10% Bonus below

Minimum 2128 shares of 8% Series A Preferred Stock ($10,001.60)

Betterpath, Inc.

Corporate Address
147 Front Street, Brooklyn, N.Y. 11201

Description of Business
  • Betterpath is a Personal Data Broker that shares profits with users who opt to collect and monetize their health data through our Consumer-directed Exchange Data Brokerage Platform ("CDX Network"). Health data assets increase in value as they become more complete, providing incentive for the user to continuously contribute more data. This enables a market for comprehensive health data that can generate robust and consistent revenues for our users, our investors, and our mission. 

Type of Security Offered
8% Series A Preferred Stock + CDX Tokens
Purchase Price of Security Offered
$4.70/share of Series A Preferred Stock

Minimum Investment Amount (per investor) 
$470 (100 shares)


CDX Tokens (CDXT)

The Offering includes 20 CDXT for every $1 invested.  ($0.050 / CDXT)

Our anticipated Reg A+ round will authorize 1,500,000,000 CDXT and offer up to 1,050,000,000 CDXT for public sale at $0.050 / CDXT.

Betterpath anticipates that successful rollout of the BetterHSA will create an increasingly valuable network of health data owners and buyers. This network is called the Consumer-directed Exchange (CDX).

CDX Tokens

Description:  The Consumer-directed Exchange Token (“CDX Token” or "CDXT") will represent a secured interest (like a share of stock) in the profits generated by the Company. Each Token will be backed by 50% of the Company’s profits, held as USD deposits in the CDX Token Trust Account (“CDX Trust”). The net asset value or NAV of each Token shall be determined by dividing the total CDX Trust balance by the number of CDX Tokens outstanding. CDX Tokens will initially be issued on the ERC20 blockchain. See Offering Document for the full set of terms.

  • Initial Blockchain: ERC20

  • Anticipated Migration to Alternative Blockchain: Cardano
  • Expected Network Launch date: End of 2019
  • Total amount of Tokens authorized for creation: 1,500,000,000
  • Amount of Tokens issued as Perks in Reg CF Round (max): 20,140,000
  • Will they be listed on Exchanges? if so, which:  The Company anticipates listing the Tokens on an ATS such as TZero

Material Terms:

  • Voting Rights: None

  • Restrictions on Transfer: 1 year from closing of Offering or at anytime should a market emerge on any registered exchange or  ATS Platform such as TZero. In addition, the Company will notify all Public CDXT holders in the 13th month following the closing of the Reg A+ round of the NAV of each Token (should one exist) and allow holders to redeem their CDXT for an amount equal to the most  recently published NAV  through the CDX Trust.

  • Dividends/Distributions: Each CDXT will be backed by USD deposits held in the CDX Token Trust Account. The Trust account will be funded with the greater of 20% of the Company’s revenue or 50% of the Company’s profits.  Deposits to the CDXT-Trust will be made at least annually in each year where the company earns a profit. If no profits are declared for 12 months following the closing of our anticipated Reg A+ Token Offering, the Company will contribute either 20% of its revenue or 50% of profits, whichever is greater to the Trust, at least annually. The net asset value or NAV of each Token shall be determined by dividing the total Trust balance by the number of Tokens outstanding. 

    • Redemption Rights: The Company will offer public Token holders the ability to redeem their Tokens at any time at the most recently published NAV. Redeemed Tokens will be considered “burned” and reduce the outstanding float. This “reverse dilution” will inure to the benefit of the remaining Token Holders as there will be a smaller denominator (less outstanding Tokens) if additional funds are added to the Trust. We believe this structure offers characteristics that are both desirable and unique.

  • Computation of Profits: The Company will calculate its profit by the amount that total revenue from all activities exceeds the expenses, costs and taxes needed to sustain and grow Betterpath’s business. Any profit that is declared will be split evenly between the Company and the CDX Trust. 

    • It is in the best interest of all Company stakeholders to establish this sharing arrangement as soon as possible even if the Company has yet to declare a profit. As such, the Company will begin contributing 20% of its Operating Revenue, at least annually,  beginning in the 13th month after the close of the A+ round. This amount will be calculated by deducting expenses associated with data acquisition (COGS) and SG&A expenses. The resulting number will be multiplied by 20% and paid to the CDX Trust. If the Company declares a profit at the end of its fiscal year that would have resulted in an amount greater than the previously contributed amount, an additional payment will be made to the CDX Trust.  




Hard Cap

Soft Cap

Notes (additional information available in the Terms section)

Public Sale




Immediately vested in the CDX Token Trust

Reg CF. Perks




20:1 CDXT match for every $1 invested

CDXT-Trust Reserve




Available for purchase from the Token Trust by the Company at the greater of published NAV or $.05/CDXT

Team Token Incentive Plan




Team TIP will function like an equity incentive plan with amounts and vesting schedules set by the Company Directors





Public Investors: CDXT purchased during the offering shall not have any transfer restrictions and may be offered for redemption at the NAV published by the CDX Trust or sold in the secondary market assuming such a market is available. The Company makes no guarantee that either a published NAV or a secondary market will be available and investors should be guided accordingly.

Rights:  All Tokens acquired as a perk in the REG CF Round shall have the same terms as those offered to the public in the anticipated TSO-Reg A+ round

CDX Trust Reserve: These Tokens will be held by the Trust as part of the total authorized by the Terms of the offering. They will be for sale continuously to the Company only, at a price that will be the greater of $.05 or the most recently published NAV. The purpose of the Reserve is to offer CDXT to our Data Contributors as an alternative to a cash payment. An example of this follows:

BetterHSA User earns $350 for establishing account and is offered the choice between USD or an equivalent amount of CDXT. We anticipate the process for compensating in CDXT will be:

  • The Company transfers $350 USD to the CDX Trust Account 
  • Assuming no published NAV, the USD amount will be divided by the public sale price of $.05/CDXT.
  • 7000 CDXT will be added to the User’s BetterHSA Account

Even though the number of outstanding CDXT will rise, no dilution will occur since there will be an equivalent amount of USD added to the Trust. 

The Company believes that allowing BetterHSA Users the option of receiving their compensation in CDXT could accelerate consumer adoption of the BetterHSA Platform and stimulate broader data contributions at the individual level.

Since the CDXT NAV and secondary market values will be driven by ongoing data contributions which lead to increased sales, we believe that BetterHSA Users will come to realize that unlocking the latent value in their healthcare data can result in financial gain that can be spent currently or held as a longer term investment. 

Team Token Incentive Plan: These Tokens will follow the same guidelines as the Company’s Equity Incentive Plan and be used as incentives to reward current Team Members and outside advisors or contractors. Tokens granted under the plan will vest immediately upon the grant date but will not have the ability to redeem through the NAV provisions of the CDXT Trust for a period of 24 months following the initial declaration of the CDXT NAV. This will prevent the possibility of the NAV being immediately diluted by the addition of the “TIP” generated Tokens. Holders of these Tokens will have no restrictions should they choose to liquidate their Tokens on a registered exchange. The Company will place restrictions of 24 months as described above on each Token that comes from the plan which any potential buyer will be subject to.

The Terms of our CDXT offering have not yet been authorized by the Board. It is the Company's intent to authorize the CDXT offering as described above, at our next Board meeting. 

The Company currently does not have a functional distributed ledger based business model nor a blockchain based token and there is no guarantee that such will be developed in the future. The promise of future tokens is contingent upon the successful development of such items.  There is no guarantee that successful development will ever occur.  The right to receive future tokens and the offering of future tokens is being offered as part of this offering exempt from registration under Regulation CF.  

Tax Advisory: Investors should consult their tax advisors with respect to the tax basis for each of the 8% Series A Preferred Stock and the CDX Tokens, since they will trade independently.


 No Investor who (i) resides, (ii) is located, (iii) has a place of business, or (iv) is conducting business (any of which makes the Investor a “Resident”) in the state of New York will be accepted in this offering.

*All perks and tokens will be delivered after the campaign is completed, and upon availability of the Tokens.

The 10% Bonus for StartEngine Shareholders

Betterpath will offer 10% additional bonus shares for all investments that are committed by StartEngine Crowdfunding Inc. shareholders (with ≥ $1,000 invested in the StartEngine Reg A+ campaign) within 24 hours of this offering going live.

StartEngine shareholders who have invested $1,000+ in the StartEngine Reg A+ campaign will receive a 10% bonus on this offering within a 24-hour window of their campaign launch date.  This means you will receive a bonus for any shares you purchase.  For example, if you buy 100 shares of 8% Series A Preferred Stock at $4.70 / share, you will receive 10 bonus shares of 8% Series A Preferred Stock , meaning you'll own 110 shares for $470.   Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid for one year from the time StartEngine Crowdfunding Inc. investors receive their countersigned StartEngine Crowdfunding Inc. subscription agreement.

Irregular Use of Proceeds

The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments and salary made to one's self, a friend or relative; Any expense labeled "Administration Expenses" that is not strictly for administrative purposes; Any expense labeled "Travel and Entertainment"; Any expense that is for the purposes of inter-company debt or back payments.

Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$2,040.00 USD
$71,399.00 USD
Cash And Cash Equivalents
$2,040.00 USD
$7,989.00 USD
Accounts Receivable
$0.00 USD
$0.00 USD
Short Term Debt
$131,694.00 USD
$115,477.00 USD
Long Term Debt
$420,000.00 USD
$310,000.00 USD
Revenues And Sales
$10,000.00 USD
$20,000.00 USD
Costs Of Goods Sold
$12,000.00 USD
$28,500.00 USD
Taxes Paid
$0.00 USD
$0.00 USD
Net Income
-$195,516.00 USD
-$459,800.00 USD


A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


A note on CDX, Tokenized Securities, and ICOs...

5 days ago

Thank you to all who have provided the incredibly positive feedback thus far! Connect with us through our social media channels, Telegram, and directly here by commenting below. As we prepare for a significant marketing push later this week and next, we want to make sure anyone who's interested in participating is equipped with the ammo they need to make an informed decision.

We believe the use of Tokenized Securities (like CDX) on the blockchain creates a significantly more favorable investment opportunity vs. a traditional "ICO". 

Any company that seeks capital must have a plan for paying it’s investors back regardless of how that money is raised. The vast majority of Token Offerings / ICO’s that have been issued and subsequently increased sharply in value will likely end up at “0” unless the issuer has a viable business that will support the value of whatever security (including tokens) have been used.

Most Companies that use ICO’s do not have a prototype or minimum viable product and instead are positioned to solicit funds with 2 elements:

  • A Whitepaper that details the company’s aspirational world changing goals

  • A healthy marketing budget

There is no way to rationalize the true value of these securities because the incentives between the issuers and the investors are not aligned. 

If an issuer has a viable business model that includes a compelling reason to use some form of token that aligns all of the company’s stakeholders AND creates an understandable path to a profitable investment, it would be rare in today’s market.

Betterpath will be such an issuer and utilize a structure that will redefine Token offerings.

We will differentiate ourselves from others in the market in 3 key ways:


The Data Brokerage model is already well established. Betterpath builds upon this model by partnering with Data Owners to create a deeper, more comprehensive data product than what's currently available from 3rd party Brokers. 


The number one limiting factor for us is consumer adoption. Since we know that consumers must be motivated to adopt any new technology, we are going to pay the first 5000 users up to $500 in cash just to start using the BetterHSA. 


Not only do our Tokens represent a secured interest in the value of the Company, but to ensure our investors can realize an early return and potentially multiply the value of their initial investment, Betterpath has committed to diverting 50% of our profits to back the value of our Tokens in $USD. 

Long story short, Betterpath is different because we're committed to putting our investors and users first. We know that there's enough latent value out there in the Data Economy that's just waiting to be captured, and believe our timing and approach is both unique and compelling. 

Feel free to reach out and ask questions, or book some time with me ( to discuss Betterpath's plans in-depth. 


- Matt Sinderbrand, CEO

It's what the people want!

5 days ago

To our early supporters: Thank you!

To our followers, check out these highlights from a recently published study on Data Ownership:


In the United States, 3 out of 4 people believe their data is their property, and that they should be able to trade it if they choose to do so – for services, discounts, or other offers. This perspective is shared across gender, age cohort, and generation.

To participate in data sharing with a company, people in the U.S. seek transparency: 

  • 84% expect terms and conditions will be easy to read and understand 
  • 83% want a flexible privacy policy allowing them to control the types and amount of data they share

The top incentives Americans prefer for sharing their data are direct financial rewards or cash payments.


Why Betterpath will lead the charge toward Data Ownership with the BetterHSA: 

  • First and only Terms of Service that explicitly shares profits with Users
  • Privacy Policy that allows users to control the types and amount of data they share
  • Users compensated with $USD (not crypto) contributed directly into their BetterHSA
  • User experience that provides tangible benefits ($) each time to motivate continuous engagement (more data)

By partnering with our Users and showing them the potential value of their data through up-front cash payments, Betterpath will stimulate the volume of adoption necessary to execute on our short-term goals. 

Stay tuned for more updates and be sure to join us on Telegram


10 days ago


We've spent the last 4 years building toward this moment, and are beyond excited to share our vision with the world. 

With the recent explosion of media coverage on data privacy and data ownership, consumers are more aware than ever that their personal data is being bought and sold by others for financial gain. We want to capitalize on this sentiment by providing consumers with opportunities to generate passive income from their data, and are in the process of finalizing the first and only Terms of Service that explicitly shares profits with Data Owners. 

The Campaign Page you just read and/or scanned through provides a lot of detail, so for reference, here's the quick pitch: 

  1. Health data is incomplete and fragmented across the health system, and the only stakeholder who can access a complete set of data is the individual patient.  
  2. Betterpath creates the access point for complete data by motivating patients as consumers, paying them in cash to collect their data through the BetterHSA.
  3. BetterHSA uniquely bridges financial and health-related activities and serves as the perfect vehicle to financially motivate consumers to engage with the health system.
  4. BetterHSA is the adoption channel for our Consumer-directed Exchange (CDX): a decentralized Network for health data that uniquely aligns all healthcare stakeholders through easier access to more comprehensive information.
  5. Unlike Facebook and Google, who transact billions each year selling access to your data without sharing profits, Betterpath pays fair market value to its users for the access and use of their valuable asset. 
  6. Users control every aspect of how their data is monetized by opting-in to opportunities like receiving targeted advertisements, fulfilling sponsored surveys, and participating in research studies. 
  7. The market for incomplete data is massive because it’s the only game in town; Betterpath unlocks the market for complete data by cooperating and sharing profits with our users, stimulating sticky user engagement and deeper data completeness over time. 
  8. Betterpath’s core IP creates and maintains an individual’s complete health record at a level of completeness that has never before existed. 
  9. We are raising capital to stimulate broad adoption of the BetterHSA and associated Consumer-directed Exchange. 
  10. Once the public begins to experience the financial benefits that their personal data can generate, cash flow from ongoing data sales and other sources should make continued adoption self sustaining.

Please feel free to submit questions or comments to, and join our Telegram channel to follow our day-to-day activities. 

Until next time! 

Matt Sinderbrand - CEO

Comments ({{profileCtrl.startup.comments_count}} total)

Show More Comments